Market Positioning BrightSpec offers a distinctive MRR spectroscopy platform that can outperform traditional methods in certain analyses, presenting a clear sales opportunity to pharma, biotech, and academic customers seeking faster, separation-free molecular identification and quantification.

Targeted Industries Focus outreach to pharmaceutical and biotech R&D, chemical/oil & gas, consumer products, security, and environmental sectors where MRR can solve isomer, isotopologue, diastereomer, and enantiomer identification gaps not easily addressed by MS or NMR.

Industry Momentum Leverage recent recognition such as the 2025 R&D 100 Award and ongoing PittCon 2025 activities to engage prospects by highlighting validation, peer adoption, and conference-driven demonstrations.

Leadership & Growth With new CEO appointment and senior sales leadership, there is a signal of strategic market expansion and customer-focused growth initiatives, offering an opportunity to align value propositions with enterprise buyers and service partnerships.

Evidence of Adoption Growing publications and collaborations across 110+ research groups demonstrate increasing credibility; use case stories and academic collaborations can be crafted into sales assets for risk-averse buyers seeking proven results.